HCA Healthcare shares have dropped 11.6% over the past six months to $423.55, underperforming the S&P 500's 9% gain. The company generated $76.39 billion in revenue over the last twelve months, giving it significant scale and supplier negotiating leverage in the hospital industry. Earnings per share grew at a 19.9% compound annual rate over five years, outpacing 7.7% annualized revenue growth, while its five-year average return on invested capital reached 28.8%. The stock now trades at 13.5 times forward earnings.
HCA Healthcare, Inc.Stock fell 11.6% over six months, underperforming S&P 500, and trades at 13.5x forward P/E, reflecting valuation concerns.